I agree that this site is using cookies. You can find further informations here.
X
Tsuji, Keiji
409  results:
Search for persons X
?
1

SAT-319 RECAM-J 2023-validation of RECAM and development of..:

Tanaka, Atsushi ; Tsuji, Keiji ; Komiyama, Yasuyuki...
Journal of Hepatology.  80 (2024)  - p. S118 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Mac-2 binding protein glycosylation isomer as a novel predi..:

Yugawa, Kyohei ; Maeda, Takashi ; Tsuji, Keiji...
Surgery Today.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

RECAM‐J 2023—Validation and development of the Japanese ver..:

Tanaka, Atsushi ; Tsuji, Keiji ; Komiyama, Yasuyuki...
Hepatology Research.  54 (2024)  6 - p. 503-512 , 2024
Link: https://doi.org/10.1111/..
 
?
4

Effect of treatment periods on efficacy of glecaprevir and ..:

Morita, Atsuhiro ; Tamaki, Nobuharu ; Kobashi, Haruhiko...
JGH Open.  8 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Therapeutic Efficacy and Safety of Lenvatinib after Atezoli..:

Yano, Shigeki ; Kawaoka, Tomokazu ; Yamasaki, Shintaro...
Cancers.  15 (2023)  22 - p. 5406 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Necessity for surveillance for hepatocellualr carcinoma in ..:

Ishido, Shun ; Tamaki, Nobuharu ; Kurosaki, Masayuki...
JGH Open.  7 (2023)  6 - p. 424-430 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Effects on survival of the adverse event of atezolizumab pl..:

Takaki, Shintaro ; Kurosaki, Masayuki ; Mori, Nami...
Investigational New Drugs.  41 (2023)  2 - p. 340-349 , 2023
Link: https://doi.org/10.1007/..
 
?
8

A case of difficult-to-diagnose hepatic reactive lymphoid h..:

Mita, Junya ; Maeda, Takashi ; Tsujita, Eiji...
International Cancer Conference Journal.  13 (2023)  1 - p. 33-39 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Significant association between HLA‐B*35:01 and onset of dr..:

Nakamura, Ryosuke ; Arakawa, Noriaki ; Tanaka, Yoichi...
Hepatology Research.  53 (2023)  5 - p. 440-449 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Japanese subgroup analysis of GLIMMER: A global Phase IIb s..:

Tanaka, Atsushi ; Atsukawa, Masanori ; Tsuji, Keiji...
Hepatology Research.  53 (2023)  7 - p. 629-640 , 2023
Link: https://doi.org/10.1111/..
 
?
11

Real‐world long‐term analysis of daclatasvir plus asunaprev..:

Fujii, Hideki ; Kimura, Hiroyuki ; Hasebe, Chitomi...
JGH Open.  6 (2022)  5 - p. 344-352 , 2022
Link: https://doi.org/10.1002/..
 
?
12

Risk factors for hepatocellular carcinoma at baseline and 1..:

Kaneko, Shun ; Kurosaki, Masayuki ; Mashiba, Toshie...
Journal of Medical Virology.  95 (2022)  1 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
13

General evaluation score for predicting the development of ..:

Tada, Toshifumi ; Kurosaki, Masayuki ; Tamaki, Nobuharu...
JGH Open.  6 (2022)  7 - p. 487-495 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Characterisation of baseline complement values in patients ..:

Cremer, Jennifer ; Richards, Anna ; Lukic, Tamara...
Journal of Hepatology.  77 (2022)  - p. S288-S290 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Efficacy and safety of bepirovirsen in patients with chroni..:

Lim, Seng Gee ; Pojoga, Cristina ; Janssen, Harry...
Journal of Hepatology.  77 (2022)  - p. S12-S13 , 2022
Link: https://doi.org/10.1016/..
 
1-15